Scientific Program
Time | Room A [English] |
---|---|
08:20-08:30 | Opening and Course Introduction |
08:30-09:10 | Keynote Lectures |
08:30-08:50 | Latest Update in Current TAVR Trials & Lifetime Management |
08:50-09:10 | Prospect in Heart Valve Surgery: Present & Future |
09:10-10:10 | HEART TEAM AT WORK, Learn from Cases: TAVR & ViV |
09:10-09:22 | From Procedure to Pathway: Longitudinal Management of TAVR Patients |
09:22-09:34 | Multimodality Imaging Workflow: From Screening to Follow-up |
09:34-09:44 | Case 1: TAVR in Special Situation |
09:44-09:54 | Case 2: Multiple Valve Disease with ViV |
09:54-10:10 | Heart Team Discussion |
10:10-10:30 | Coffee Braek |
10:30-11:30 | Hot Topics in TAVR |
10:30-10:42 | Selection of Valve: What Should I Consider |
10:42-10:54 | SAVR Is Still Good : Sutureless AVR 10 Year Clincal Outcomes |
10:54-11:06 | Coronary Artery Disease in TAVI Patients |
11:06-11:18 | TAVR in Bicuspid AV |
11:18-11:30 | Panel Discussion |
11:30-12:30 | HEART TEAM AT WORK, Learn from Cases: T-TEER |
11:30-11:42 | Functional TR: When to Intervene, When to Observe? |
11:42-11:54 | Tricuspid Valve Repair: Surgery or Transcatheter? |
11:54-12:04 | Case 1: T-TEER for Functional TR |
12:04-12:14 | Case 2: PIVOT-Bridge for Severe TR |
12:14-12:30 | Panel Discussion |
12:30-13:30 | Luncheon Session (Edwards Sponsored Session) |
12:30-12:50 | TAVR: Sapien |
12:50-13:10 | M-TEER: PASCAL |
13:30-14:30 | Advances in Transcatheter Tricuspid Valve Intervention |
13:30-13:42 | Optimal 3D TEE Imaging for TR Intervention |
13:42-13:54 | How to Image the Tricuspid Valve with 3D ICE? |
13:54-14:06 | New Kids on the Blocks: T-TEER vs TTVR |
14:06-14:18 | Challenging Candidates for TEER and New Solutions |
14:18-14:30 | Panel Discussion |
14:30-14:50 | Coffee Braek |
14:50-15:50 | Diagnosis and Treatment of Patients with AR |
14:50-15:02 | Mechanisms of Aortic Regurgitation and Grading of Aortic Regurgitation |
15:02-15:14 | Aortic Regurgitation: Timing of Aortic Valve Intervention, What Do the Guidelines Say? |
15:14-15:26 | Recent Update in Surgery for Pure AR |
15:26-15:38 | TAVR in Pure Native AR |
15:38-15:50 | Panel Discussion |
15:50-16:50 | Transcatheter Treatment in Other Structural Heart Disease |
15:50-16:02 | Recent Update in PPVR |
16:02-16:14 | PVL Occlusion |
16:14-16:26 | Tip & Tricks for PMV |
16:26-16:38 | 2D & 3D ICE Guided LAAO |
16:38-16:50 | Panel Discussion |
16:50-17:10 | Coffee Braek |
17:10-18:10 | 2025 SHD in Asia: New Innovation of SHD Intervention & Surgery |
17:10-17:22 | Virtual Reality Imaging for Mitral Valve Repair Based on Artificial Intelligence Predictions |
17:22-17:34 | Future Devices for MV & TV Intervention |
17:34-17:46 | Robotics in Heart Valve Surgery |
17:46-17:58 | Overview & Clinical Application of Electrosurgery |
17:58-18:10 | Panel Discussion |
18:10 | Closing Remark |
Time | Room B [Korea] |
---|---|
09:10-10:10 | From the OR to the Reading Room: A True Dialogue |
09:10-09:22 | Valve Repair from A to Z |
09:22-09:34 | What I Wish I Knew Before and After Repair |
09:34-09:46 | Answers from the Imaging Cardiologist |
09:46-09:58 | Answers from the Radiologist |
09:58-10:10 | Panel Discussion |
10:10-10:30 | Coffee Break |
10:30-11:30 | When Rhythm Meets Valves: Managing the Arrhythmia-Valve Disease Nexus |
10:30-10:42 | AF Fundamentals for Structural Heart Team |
10:42-10:54 | MAZE at the Time of Valve Surgery: Evidence, Evolution, and Patient Selection in 2025 |
10:54-11:06 | Atrial Functional MR/TR with AF: When to Intervene on the Valve? |
11:06-11:18 | Ventricular Arrhythmias in Valve Disease: Red Flags Every Structural Heart Team Must Recognize |
11:18-11:30 | Panel Discussion |
11:30-12:30 | Contemporary Surgical Valve Techniques: What Imaging Cardiologists Need to Know |
11:30-11:42 | Minimally Invasive and Robotic Valve Surgeries |
11:42-11:54 | Sutureless & Rapid Deployment Valves |
11:54-12:06 | What’s New in Mechanical Valves |
12:06-12:18 | Troubleshooting Complex Valve Cases: MAC, Small Annulus, and Other Challenges |
12:18-12:30 | Panel Discussion |
12:30-13:30 | Luncheon Session (Handok Sponsored Session) |
12:30-12:50 | |
12:50-13:10 | |
13:30-14:30 | Great Debate #2: 70-Year-Old Male with Severe Ventricular Functional MR |
13:30-13:35 | Opening Lecture and Pre-voting |
13:35-13:45 | TEER |
13:45-13:55 | Surgical MV Repair or Replacement |
13:55-14:15 | Crossfire & Panel Discussion |
14:15-14:30 | Final Voting & Wrap-up |
14:30-14:50 | Coffee Braek |
14:50-15:50 | Congenital Heart Disease that Cardiologist Must Know |
14:50-15:02 | ASD Closure: Who Truly Benefits and Who Might Suffer? |
15:02-15:14 | Complex Congenital Heart Disease in Adults: What Cardiologists Shouldn’t Miss |
15:14-15:26 | Congenital Pulmonary Valve Disease: A Lifetime Management Perspective |
15:26-15:38 | Congenital Aortic Valve Disease in Adult |
15:35-15:50 | Panel Discussion |
15:50-16:50 | The Right Focus: Mastering Tricuspid Valve Imaging |
15:50-16:02 | Right Heart Anatomy and Imaging |
16:02-16:14 | TR Phenotyping and Etiology |
16:14-16:26 | TR Severity Assessment |
16:26-16:38 | Beyond Echo: CT & CMR Insights |
16:38-16:50 | Panel Discussion |
Time | Room B [Korea] |
---|---|
08:30-10:10 | Rare Genetic Disease Involving Heart |
08:30-08:45 | Pompe Disease Related to Cardiovascular Involvement |
08:45-09:00 | Mucopolysaccharidosis Related to Heart and Cardiovascular Involvement: Incidence and Response to Therapy |
09:00-09:15 | Barth Syndrome Related Dilated Cardiomyopahty |
09:15-09:30 | Genetic Cardiomyopathy |
09:30-09:45 | Genetic Disease Related Arrhythmia |
09:45-10:10 | Panel Discussion |
10:10-10:40 | Coffee Break |
10:40-12:30 | Genetics in Structural Heart Disease |
10:40-10:55 | Basics of Fenetic Testing for Cardiologists |
10:55-11:10 | Evolution of Genetic Testing: Past, Now, and Future |
11:10-11:25 | Interpretation of Genetic Tests for Cardiomyopathies: Case-based Learning |
11:25-11:40 | Long-read Sequencin in Congenital Heart Disease |
11:40-11:55 | Genetic Counseling in Structural Heart Disease |
11:55-12:30 | Panel Discussion |
12:30-13:30 | Luncheon Session (Takeda Sponsored Session) |
13:30-15:00 | Special Session for Fabry Disease |
13:30-13:45 | Genome-Edited iPS Therapy for Fabry Disease |
13:45-14:00 | Advances & Future Treatment in Fabry Disease |
14:00-14:15 | Multimodality Imaging for Evaluating Treatment Response in Fabry Disease |
14:15-14:30 | Neuroimaging in Fabry Disease: Current Knowledge and Future Directions |
14:30-14:45 | Optimizing Fabry Disease Care Through a Multidisciplinary Team-based Model |
14:45-15:00 | Panel Discussion |